Different Amoxicillin Treatment Regimens in Erythema Migrans Patients

Last updated: November 28, 2023
Sponsor: University Medical Centre Ljubljana
Overall Status: Active - Recruiting

Phase

N/A

Condition

Skin Wounds

Hives (Urticaria)

Rash

Treatment

EM-amoxicillin 3 x 10 days

EM-amoxicillin 3 x 14 days

Controls

Clinical Study ID

NCT03966014
Amoxy 10-15
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to compare the efficacy of different amoxicilline treatment regimens in patients with erythema migrans.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • erythema migrans

Exclusion

Exclusion Criteria:

  • pregnancy
  • extracutaneous manifestations of Lyme borreliosis
  • immunocompromising state
  • serious adverse event to beta lactam antibiotic
  • receiving antibiotic with antiborrelial activity within 10 days

Study Design

Total Participants: 510
Treatment Group(s): 4
Primary Treatment: EM-amoxicillin 3 x 10 days
Phase:
Study Start date:
June 01, 2019
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • University Medical Centre Ljubljana

    Ljubljana,
    Slovenia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.